View Clinical Trial (Medical Research Study)

A Study of HIV-infected Subjects Initiating Anti-HIV Drugs for the First Time - NCT00595192-19102(Clinical Trial 198486)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Philadelphia
State:  
PA
Zip Code: 19102
Conditions: HIV Infections
Purpose: Subjects who are ready to start anti-retroviral therapy (ART) will be screened to see if they are eligible for this study. If interested, patient will enroll in this study the same day they are going to start their ART. A blood sample will be obtained that day before they start ART. This sample will be frozen and sent to a special lab at Argos Therapeutics to be stored until the subject's personalized vaccine can be created. We are not certain that a vaccine can be created for everyone. Subjects will be under no obligation to receive the vaccine if it is made.
Study summary:
Criteria: Inclusion Criteria: - Patients have never taken ARVs,have had a minimum of a twelve week break in regimen,or only as post exposure prophylaxis or for less that 14 days. - Viral load at least 8,000 - CD4 count at least 200 within 30 days of study enrollment Exclusion Criteria: - Prior use of HIV Vaccine - Hepatitis B surface antibody positive - Hepatitis C positive - Positive syphilis - History of or evidence of severe illness/malignancy
Study is available at: Drexel University College of Medicine
Philadelphia, PA 19102
United States

Primary Contact:
Sharon Lewis, RN,BSN, CCRN
Email: slewis@drexelmed.edu
Phone: 215-762-3251
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.